ProSomnus, Inc. Common Stock
OSA
$-0.04
Change (1 day)
$5.15
Year High
$0.10
Year Low
Categories
Prosomnus Sleep Technologies, Inc. designs, manufactures, and markets sleep apnea therapy devices for dentists to treat patients diagnosed with obstructive sleep apnea. The company was incorporated in 2016 and is based in Pleasanton, California.
P/S ratio for ProSomnus, Inc. Common Stock (OSA)
P/S ratio as of 2023: 0.57
According to ProSomnus, Inc. Common Stock's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.57. At the end of 2022 the company had a P/S ratio of 2.87.
P/S ratio history for ProSomnus, Inc. Common Stock from 2020 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 0.57 |
| 2022 | 2.87 |
| 2021 | 2.77 |
| 2020 | 18.67 |